Jump to content
We have moved on. Click this line for PCFA Online Community, Facebook groups for men, for carers, AnswerCancer

New agents

Drugs and other treatments of the future - under trial or newly approved.

Followers 139

127 topics in this forum

  1. New use of an older drug Lynparza® (olaparib) approved by the FDA for metastatic castrate resistant men who have damage to their BRCA1/2 genes

    By Admin,
    • 4 replies
    • 210 views

  2. New drug Rubraca approved by the FDA for metastatic castrate resistant men who have damage to their BRCA1/2 genes

    By Admin,
    • 1 reply
    • 120 views

  3. Olaparib + Zytiga for Metastatic Castrate-Resistant Prostate Cancer: PCRI video

    By Admin,   
    • 1 reply
    • 293 views

  4. Why Lutetium-177 hasn't worked for some men - from the "New" Prostate Cancer Infolink

    By Admin,   
    • 0 replies
    • 315 views

  5. USA FDA approves Xtandi (enzalutamide) for use with hormone sensitive metastatic prostate cancer

    By Admin,
    • 1 reply
    • 117 views

  6. THERANOSTICS

    By Barree,   
    • 12 replies
    • 518 views

  7. Epigenetics research shows great promise

    By tonymax,   
    • 2 replies
    • 684 views

  8. MORE LUTETIUM CLINICAL TRIALS ON THE WAY

    By Barree,   
    • 6 replies
    • 651 views

  9. NUCLEAR MEDICINE NEW DEVELOPMENTS PETER MAC VIDEO

    By Barree,   
    • 1 reply
    • 227 views

  10. 'The Language of Cancer' Webinar coming up tomorrow!!

    By ardee,
    • 0 replies
    • 129 views

  11. LUTETIUM 177 PRE TREATMENT SCANS

    By Barree,   
    • 0 replies
    • 341 views

  12. AMG 160

    By Kezza2,
    • 3 replies
    • 1k views

  13. New drug Apalutamide (Erlyand) not approved for the PBS in Australia

    By Admin,
    • 3 replies
    • 816 views

  14. Adding abiraterone after enzalutamide fails does not help enzalutamide responders

    By Admin,
    • 3 replies
    • 276 views

  15. New radioactive Lutetium trial in the USA

    By Admin,
    • 2 replies
    • 902 views

  16. Faster way for new drug approval in advanced prostate cancer

    By Admin,
    • 0 replies
    • 392 views

  17. lutetium 177 treatment any experience

    By susan horn,
    • 9 replies
    • 3.8k views

  18. BRCA mutation and PARP inhibitors

    By MBarry,
    • 4 replies
    • 613 views

  19. No mets but PSA rising on ADT: USA FDA approves new drug Erleada (apalutamide) to delay mets

    By Admin,   
    • 4 replies
    • 608 views

  20. Yesterday at ASCO: Enzalutamide on rapidly rising PSA before metastasis looking good

    By Admin,   
    • 0 replies
    • 467 views

  21. Profound Trial (Olaparib) BRCA mutation

    By MBarry,   
    • 7 replies
    • 1.9k views

  22. Abiraterone (Zytiga) 3/3 The Australian position

    By Admin,   
    • 6 replies
    • 1k views

  23. Abiraterone (Zytiga) 2/3 LATITUDE trial results

    By Admin,   
    • 0 replies
    • 783 views

  24. Abiraterone (Zytiga) 1/3 STAMPEDE trial results

    By Admin,   
    • 0 replies
    • 653 views

  25. Abiraterone early but not for Aussies as yet?

    By pauldhodson,   
    • 1 reply
    • 613 views
×
×
  • Create New...